Evidence map›Paper›PMID 35228725›Full record

ArticleNature methods2022

Targeted multicolor in vivo imaging over 1,000 nm enabled by nonamethine cyanines.

Venu G Bandi, Michael P Luciano, Mara Saccomano, Nimit L Patel, Thomas S Bischof, Jakob G P Lingg, Peter T Tsrunchev, Meredith N Nix, Bastian Ruehle, Chelsea Sanders and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. More Than a Glow: How Cyanine Dyes Shape Tracer Pharmacokinetics.Angewandte Chemie (International ed. in English) · 2026
    Review
  2. Modern Cyanine Dye-Based Photosensitizers for Medical Applications.Angewandte Chemie (International ed. in English) · 2026
    Review
  3. Silicon Flavylium Polymethine Dyes for Shortwave Infrared Imaging.Journal of the American Chemical Society · 2026
    Article
  4. Article
  5. De Novo Design of Near-Infrared Fluorescence-Activating Proteins.Journal of the American Chemical Society · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. In Situ Lipoprotein-seeking Dye for in Vivo Real-Time Imaging of Lipid Dysregulation Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. High-Resolution Multicolor Shortwave Infrared DynamicJournal of the American Chemical Society · 2025
    Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Venu G Bandi *Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Michael P Luciano *Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-1996-1587
Mara Saccomano *Helmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.
Nimit L PatelSmall Animal Imaging Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Thomas S BischofHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.
Jakob G P LinggHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.
Peter T TsrunchevHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-8459-6520
Meredith N NixChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Bastian RuehleBiophotonics Division, Federal Institute of Materials Research and Testing, BAM, Berlin, Germany.ORCID http://orcid.org/0000-0003-3383-9999
Chelsea SandersAnimal Research Technical Support, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Lisa RiffleSmall Animal Imaging Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Christina M RobinsonAnimal Research Technical Support, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Simone DifilippantonioAnimal Research Technical Support, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.
Joseph D KalenSmall Animal Imaging Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-7163-4604
Ute Resch-GengerBiophotonics Division, Federal Institute of Materials Research and Testing, BAM, Berlin, Germany.ORCID http://orcid.org/0000-0002-0944-1115
Joseph IvanicAdvanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, MD, USA.ORCID http://orcid.org/0000-0003-2104-7169
Oliver T BrunsHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany. oliver.bruns@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0002-5738-0126
Martin J SchnermannChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. martin.schnermann@nih.gov.ORCID http://orcid.org/0000-0002-0503-0116

Funding

Synthesis and evaluation of small-molecule imaging agentsZIABC011506 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNERMANN, MARTIN · 2013 to 2025
$12.1M
NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Recent progress has shown that using wavelengths between 1,000 and 2,000 nm, referred to as the shortwave-infrared or near-infrared (NIR)-II range, can enable high-resolution in vivo imaging at depths not possible with conventional optical wavelengths. However, few bioconjugatable probes of the type that have proven invaluable for multiplexed imaging in the visible and NIR range are available for imaging these wavelengths. Using rational design, we have generated persulfonated indocyanine dyes with absorbance maxima at 872 and 1,072 nm through catechol-ring and aryl-ring fusion, respectively, onto the nonamethine scaffold. Multiplexed two-color and three-color in vivo imaging using monoclonal antibody and dextran conjugates in several tumor models illustrate the benefits of concurrent labeling of the tumor and healthy surrounding tissue and lymphatics. These efforts are enabled by complementary advances in a custom-built NIR/shortwave-infrared imaging setup and software package for multicolor real-time imaging.

Indexed as

Fluorescent DyesNeoplasmsAntibodies, MonoclonalHumansOptical ImagingSpectroscopy, Near-InfraredAntibodies, MonoclonalFluorescent Dyes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.